Unveiling the Q-Vera and Q-Vera Pico

Lusis Biosciences, a leader in molecular reagents and instruments, announces the launch of two groundbreaking quantitative PCR instruments, the Q-Vera and the Q-Vera Pico.

The Q-Vera and Q-Vera Pico are engineered to be fast, reliable, and affordable instruments for molecular laboratories. The Q-Vera is a 96-well qPCR instrument that boasts faster ramp rates compared with most other qPCR instruments on the market. The Q-Vera Pico features six individual 8-well blocks, offering unparalleled flexibility. These devices deliver precision, speed, and versatility for laboratories and research facilities.

Both instruments offer strong multiplexing capabilities of up to eight channels. This facilitates the simultaneous detection of multiple targets in a single well, enhancing the efficiency of workflows and enabling comprehensive analyses in a single run.

Durability and ease of use are key features of the Q-Vera and Q-Vera Pico. These instruments require minimal setup and maintenance, with robust construction ensuring long-term reliability—making them an excellent investment for any laboratory.

The Q-Vera Pico offers six different, individually controlled blocks, allowing users to execute up to six qPCR protocols simultaneously. This versatility also leads to more efficient use of qPCR consumables and instruments, especially when processing only a few samples.

“At Lusis, our mission is to offer a Total Solution Partnership for labs through leading-edge products and world-class service," said Chi Chen, CEO of Lusis Biosciences. "The introduction of the Q-Vera and Q-Vera Pico, two beautifully designed qPCR instruments with high multiplexing capabilities, represents a significant milestone in our commitment to advancing molecular research. These instruments are engineered to meet the evolving needs of laboratories, offering unmatched precision, efficiency, and ease of use.”